In this edition of Law360’s Coronavirus Q&A, Becky Wood, leader of the Food, Drug and Medical Device Regulatory practice and former chief counsel of the FDA, discusses the agency’s pandemic-era performance, looming court clashes over legal immunity for COVID-19 products, and why the crisis could be an inflection point for the FDA approval process.
Becky shared the perspective as part of a series of interviews Law360 is conducting with prominent lawyers regarding the legal, regulatory and business challenges of the coronavirus crisis.
Click here to view the article.